These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10805197)

  • 1. Developmental changes in cerebrospinal fluid concentrations of monoamine-related substances revealed with a Coulochem electrode array system.
    Takeuchi Y; Matsushita H; Sakai H; Kawano H; Yoshimoto K; Sawada T
    J Child Neurol; 2000 Apr; 15(4):267-70. PubMed ID: 10805197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Age changes in concentrations of monoamines and related substances in the cerebrospinal fluid].
    Takahashi S; Abe T
    No To Shinkei; 1991 Apr; 43(4):331-6. PubMed ID: 1716119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental changes in cerebrospinal fluid concentrations of monoamine-related substances in patients with dentatorubral-pallidoluysian atrophy.
    Takeuchi Y; Matsushita H; Sakai H; Kawano H; Ochi M
    J Child Neurol; 2001 Feb; 16(2):79-82. PubMed ID: 11292229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in CSF neurotransmitters during the first year of life.
    Yamamoto H
    Pediatr Neurol; 1991; 7(6):406-10. PubMed ID: 1686707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Developmental changes in the concentrations of CSF neurotransmitter metabolites].
    Yamamoto H; Egawa B; Horiguchi K; Kaku A; Yamada K
    No To Hattatsu; 1993 Jan; 25(1):40-4. PubMed ID: 8093228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid monoamine precursors and metabolites in human neonates following in utero cocaine exposure: a preliminary study.
    Needlman R; Zuckerman B; Anderson GM; Mirochnick M; Cohen DJ
    Pediatrics; 1993 Jul; 92(1):55-60. PubMed ID: 8516085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine metabolites in the cerebrospinal fluid in infantile spinal muscular atrophy.
    Takeuchi Y; Komatsu H; Matsuo S; Hirai K; Kawase S; Nishimura A; Sawada T
    Neuroreport; 1994 Apr; 5(8):898-900. PubMed ID: 8061291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of age on concentrations of monoamines, amino acids, and their related substances in the cerebrospinal fluid.
    Tohgi H; Takahashi S; Abe T
    J Neural Transm Park Dis Dement Sect; 1993; 5(3):215-26. PubMed ID: 8369101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRH increases cerebrospinal fluid concentration of kynurenine.
    Takeuchi Y; Matsushita H; Kawano H; Sakai H; Yoshimoto K; Sawada T
    Neuroreport; 1999 Nov; 10(17):3601-3. PubMed ID: 10619651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ; Walsh FX; Bird ED; Levy HL
    Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin-releasing hormone in treatment of intractable epilepsy: neurochemical analysis of CSF monoamine metabolites.
    Takeuchi Y; Tominaga M; Mitsufuji N; Yamazoe I; Kawase S; Nishimura A; Matsuo S; Sawada T
    Pediatr Neurol; 1995 Feb; 12(2):139-45. PubMed ID: 7540012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoamines, monoamine metabolites, neuron specific enolase and myelin basic protein concentrations in cerebrospinal fluid of resuscitated patients].
    Takahashi T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Feb; 17(1):7-16. PubMed ID: 9134533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of monoamine neurotransmitter metabolite analysis in cerebrospinal fluid.
    Hyland K
    Clin Chem; 2008 Apr; 54(4):633-41. PubMed ID: 18310141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of amino acids on neurotransmitter metabolites in the cerebrospinal fluid].
    Zeman J; Böswart J
    Cas Lek Cesk; 1991 May; 130(14):425-7. PubMed ID: 1712669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of sapropterin on urinary monoamine metabolites in phenylketonuria.
    Douglas TD; Jinnah HA; Bernhard D; Singh RH
    Mol Genet Metab; 2013 Jul; 109(3):243-50. PubMed ID: 23712020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serotonin and monoamine metabolites in cerebrospinal fluid in children: interrelationships and the influence of age, sex and precursor].
    Liao W
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Feb; 24(1):41-4, 63. PubMed ID: 1651218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative and quantitative high performance liquid chromatographic analysis of monoamine neurotransmitters and metabolites in cerebrospinal fluid and brain tissue using reductive electrochemical detection.
    Schmidt D; Roznoski M; Ebert MH
    Biomed Chromatogr; 1990 Sep; 4(5):215-20. PubMed ID: 1980626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
    Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine.
    Nikisch G; Baumann P; Kiessling B; Reinert M; Wiedemann G; Kehr J; Mathé AA; Piel M; Roesch F; Weisser H; Schneider P; Hertel A
    J Psychiatr Res; 2010 Sep; 44(12):754-9. PubMed ID: 20176367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.